Stock Price
4.17
Daily Change
0.05 1.09%
Monthly
7.62%
Yearly
168.71%
Q2 Forecast
4.04

Intrexon reported $287K in Stock for its fiscal quarter ending in December of 2022.





Stock Change Date
Amgen USD 6.22B 121M Dec/2025
Anika Therapeutics USD 22.84M 4.05M Mar/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
AstraZeneca USD 6.57B 13M Mar/2026
Bristol-Myers Squibb USD 2.76B 66M Mar/2026
Gilead Sciences USD 1.77B 11M Dec/2025
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Incyte USD 115.62M 14.56M Mar/2026
Intrexon USD 287K 68K Dec/2022
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Ligand Pharmaceuticals USD 9.13M 2.77M Dec/2025
MacroGenics USD 7.91M 840K Dec/2025
MannKind USD 35.31M 8.34M Dec/2025
Merck USD 6.66B 214M Dec/2025
Novartis USD 6.27B 152M Dec/2025
Rigel Pharmaceuticals USD 13.3M 2.88M Sep/2025
Roche Holding CHF 7.6B 9M Jun/2025
Thermo Fisher Scientific USD 5.5B 71M Mar/2026
Veracyte USD 20.55M 219K Dec/2025